Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats
- PMID: 10455265
- PMCID: PMC1566111
- DOI: 10.1038/sj.bjp.0702633
Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats
Abstract
The effect of the 5-hydroxytryptamine (5-HT) and noradrenaline (NA) reuptake inhibitor sibutramine was studied in food deprived, neuropeptide Y (NPY)- or muscimol-injected rats. Sibutramine dose-dependently reduced feeding caused by food-deprivation (ED50 = 5.1+/-0.8 mg kg(-1)) or by NPY injection into the paraventricular nucleus of the hypothalamus (ED50 = 6.0+/-0.5 mg kg(-1)). The increase in food intake caused by muscimol injected into the dorsal raphe was not modified by sibutramine (1-10 mg kg(-1)). The hypophagic effect of 5.1 mg kg(-1) sibutramine in food-deprived rats was studied in rats pretreated with different serotonin receptor antagonists. Metergoline (non-selective, 0.3 and 1.0 mg kg(-1)), ritanserin (5-HT2A/2C, 0.5 and 1.0 mg kg(-1)) and GR127935 (5-HT1B/1D), 0.5 and 1.0 mg kg(-1)) did not modify the hypophagic effect of sibutramine, while SB206553 (5-HT2B/2C, 5 and 10 mg kg(-1)) slightly but significantly reduced it (Fint(2.53) = 3.4; P<0.05). The reduction in food intake caused by 6.0 mg kg(-1) sibutramine in NPY-injected rats was not modified by GR127935 (1.0 mg kg(-1)). The results suggest that, with the possible exception of a partial involvement of 5-HT2B/2C receptors in sibutramine's hypophagia in food-deprived rats, 5-HT1 and 5-HT2 receptor subtypes do not play an important role in the hypophagic effect of sibutramine, at least in the first 2 h after injection.
Figures



Similar articles
-
5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.Obesity (Silver Spring). 2009 Mar;17(3):467-73. doi: 10.1038/oby.2008.550. Epub 2008 Dec 11. Obesity (Silver Spring). 2009. PMID: 19219064
-
Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat.Br J Pharmacol. 1997 Aug;121(8):1613-8. doi: 10.1038/sj.bjp.0701311. Br J Pharmacol. 1997. PMID: 9283694 Free PMC article.
-
Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.Br J Pharmacol. 1998 Aug;124(8):1781-7. doi: 10.1038/sj.bjp.0702028. Br J Pharmacol. 1998. PMID: 9756397 Free PMC article.
-
Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine.Int J Obes Relat Metab Disord. 1998 Aug;22 Suppl 1:S18-28; discussion S29. Int J Obes Relat Metab Disord. 1998. PMID: 9758240 Review.
-
Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.Adv Exp Med Biol. 1991;294:377-88. doi: 10.1007/978-1-4684-5952-4_35. Adv Exp Med Biol. 1991. PMID: 1837683 Review.
Cited by
-
A systematic investigation of the differential roles for ventral tegmentum serotonin 1- and 2-type receptors on food intake in the rat.Brain Res. 2016 Oct 1;1648(Pt A):54-68. doi: 10.1016/j.brainres.2016.07.016. Epub 2016 Jul 16. Brain Res. 2016. PMID: 27431937 Free PMC article.
-
Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.Neuropsychopharmacology. 2010 Jun;35(7):1464-76. doi: 10.1038/npp.2010.16. Epub 2010 Mar 3. Neuropsychopharmacology. 2010. PMID: 20200509 Free PMC article.
-
Reversal of sibutramine-induced anorexia with a selective 5-HT(2C) receptor antagonist.Psychopharmacology (Berl). 2011 Apr;214(4):941-7. doi: 10.1007/s00213-010-2106-2. Epub 2010 Dec 8. Psychopharmacology (Berl). 2011. PMID: 21140257
-
Neuropsychiatric adverse effects of centrally acting antiobesity drugs.CNS Neurosci Ther. 2011 Oct;17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x. Epub 2010 Jul 7. CNS Neurosci Ther. 2011. PMID: 21951371 Free PMC article. Review.
-
Effects of sibutramine in non-dieting obese women.J Endocrinol Invest. 2002 Feb;25(2):101-5. doi: 10.1007/BF03343971. J Endocrinol Invest. 2002. PMID: 11929078 Clinical Trial.
References
-
- BENDOTTI C., SAMANIN R. The role of putative 5-HT1A and 5-HT1B receptors in the control of feeding in rats. Life Sci. 1987;41:635–642. - PubMed
-
- BORSINI F., BENDOTTI C., PRZEWLOCKA B., SAMANIN R. Monoamine involvement in the overeating caused by muscimol injection in the rat nucleus raphe dorsalis and the effects of d-fenfluramine and d-amphetamine. Eur. J. Pharmacol. 1983;94:109–115. - PubMed
-
- CHEETHAM S.C., VIGGERS J.A., BUTLER S.A., PROW M.R., HEAL D.J. [3H]Nisoxetine-A radioligand for noradrenaline reuptake sites: correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 1996;35:63–70. - PubMed
-
- CHEETHAM S.C., VIGGERS J.A., SLATER N.A., HEAL D.J., BUCKETT W.R. [3H]Paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 1993;32:737–743. - PubMed
-
- CURZON G., GIBSON E.L., OLUYOMI A.O. Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. TiPS. 1997;18:21–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous